Tatva Chintan Pharma IPO vs Windlas Biotech IPO

Comparision between Tatva Chintan Pharma IPO and Windlas Biotech IPO.

IPO Details

Tatva Chintan Pharma IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Windlas Biotech IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

	Tatva Chintan Pharma IPO	Windlas Biotech IPO
Logo
Issue Category	Mainline	Mainline
Issue Type	IPO	IPO
Process Type	Book Built Issue	Book Built Issue
Listing At	BSE, NSE	BSE, NSE
Lead Managers	ICICI Securities Limited Jm Financial Limited	Dam Capital Advisors Ltd (Formerly Idfc Securities Ltd) Iifl Securities Ltd SBI Capital Markets Limited
Registrar	Link Intime India Private Ltd	Link Intime India Private Ltd
Market Maker
DRHP	DRHP	DRHP
RHP	RHP	RHP
Anchor Investor
IPO Allotment URL	IPO Allotment URL	IPO Allotment URL

Issue Size and Price

The total issue size of Tatva Chintan Pharma IPO is up to ₹500.00 Cr whereas the issue size of the Windlas Biotech IPO is up to ₹401.54 Cr. The final issue price of Tatva Chintan Pharma IPO is ₹1,083.00 per share and of Windlas Biotech IPO is ₹460.00 per share.

	Tatva Chintan Pharma IPO	Windlas Biotech IPO
Face Value	₹10 per share	₹5 per share
Issue Price (Lower)	₹1,073.00 per share	₹448.00 per share
Issue Price (Upper)	₹1,083.00 per share	₹460.00 per share
Issue Price (Final)	₹1,083.00 per share	₹460.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size	13 shares	30 shares
Fresh Issue Size
Fresh Issue Size (Amount)	up to ₹225.00 Cr	up to ₹165.00 Cr
OFS Issue Size		51,42,067 shares
OFS Issue Size (Amount)	up to ₹275.00 Cr	up to ₹236.54 Cr
Issue Size Total
Issue Size Total (Amount)	up to ₹500.00 Cr	up to ₹401.54 Cr

IPO Timetable

Tatva Chintan Pharma IPO opens on Jul 16, 2021, while Windlas Biotech IPO opens on Aug 04, 2021. The closing date of Tatva Chintan Pharma IPO and Windlas Biotech IPO is Jul 20, 2021, and Aug 06, 2021, respectively.

	Tatva Chintan Pharma IPO	Windlas Biotech IPO
Anchor Bid Date
Issue Open	Jul 16, 2021	Aug 04, 2021
Issue Close	Jul 20, 2021	Aug 06, 2021
Basis Of Allotment (Tentative)	Jul 26, 2021	Aug 11, 2021
Initiation of Refunds (Tentative)	Jul 27, 2021	Aug 12, 2021
Credit of Share (Tentative)	Jul 28, 2021	Aug 13, 2021
Listing date (Tentative)	Jul 29, 2021	Aug 16, 2021
Anchor Lockin End date 1	Aug 25, 2021	Sep 10, 2021
Anchor Lockin End date 2	Oct 24, 2021	Nov 09, 2021

Financials

Tatva Chintan Pharma IPO P/E ratio is , as compared to Windlas Biotech IPO P/E ratio of .

Tatva Chintan Pharma IPO

Windlas Biotech IPO

Financial

Summary of financial Information (Restated Consolidated)
Particulars	For the year/period ended (₹ in million)
	31-Mar-21	31-Mar-20	31-Mar-19
Total Assets	3,148.03	2,489.38	1,875.08
Total Revenue	3,062.92	2,646.22	2,068.01
Profit After Tax	522.62	377.89	205.43

Summary of financial Information (Restated Consolidated)
Particulars	For the year/period ended (₹ in million)
	31-Mar-21	31-Mar-20	31-Mar-19
Total Assets	2,961.23	3,384.88	2,981.80
Total Revenue	4,306.95	3,313.39	3,115.25
Profit After Tax	155.70	162.13	638.22

Promoter Shareholding (Pre-Issue)

100%

78%

Promoter Shareholding (Post-Issue)

79.17%

65.16%

P/E Ratio

Market Cap

ROE

ROCE

Debt/Equity

EPS

RoNW

Shares Offered

In the Tatva Chintan Pharma IPO retail investors (RII) are offered 16,30,941 shares while in Windlas Biotech IPO retail investors are offered 16,30,941 shares. Qualified institutional buyers (QIB) are offered 9,31,966 shares in Tatva Chintan Pharma IPO and 17,23,700 shares in Windlas Biotech IPO.

	Tatva Chintan Pharma IPO	Windlas Biotech IPO
Anchor Investor Reserveration
Market Maker Reserveration
QIB	9,31,966 shares	17,23,700 shares
NII	6,98,975 shares	13,23,766 shares
RII	16,30,941 shares	30,88,786 shares
Employee	0 shares	0 shares
Others
Total	32,61,882 shares	61,36,252 shares

Bids Received (Subscription)

Tatva Chintan Pharma IPO subscribed 180.36x in total, whereas Windlas Biotech IPO subscribed 22.44x.

	Tatva Chintan Pharma IPO	Windlas Biotech IPO
QIB (times)	185.23x	24.40x
NII (times)	512.22x	15.73x
Big NII (times)
Small NII (times)
RII (times)	35.35x	24.22x
Employee (times)
Other (times)
Total (times)	180.36x	22.44x

Compare with others

Tatva Chintan Pharma IPO	Windlas Biotech IPO
Windlas Biotech IPO	Chemplast Sanmar IPO
Exxaro Tiles IPO	Aptus Value Housing Finance IPO
Nuvoco IPO	Krsnaa Diagnostics IPO
Rolex Rings IPO	CarTrade Tech IPO
Paytm IPO	Devyani International IPO
Zomato IPO	Exxaro Tiles IPO
Glenmark Life Sciences IPO	Nuvoco IPO
Clean Science IPO	Rolex Rings IPO
G R Infraprojects IPO	Paytm IPO
India Pesticides IPO	Tatva Chintan Pharma IPO

Comments

Add a public comment...